調査レポートカテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

Global Nuclear Medicine Market 2016-2020

核医学の世界市場：核医学装置、SPECT、PET、放射性医薬品

◆タイトル：Global Nuclear Medicine Market 2016-2020
◆商品コード：IRTNTR9188
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2016年7月15日
◆ページ数：73
◆資料形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名利用）USD2,500 ⇒換算￥260,000見積依頼/購入/質問フォーム
Five User（～5名利用）USD3,000 ⇒換算￥312,000見積依頼/購入/質問フォーム
Enterprise License（全社内共有可）USD4,000 ⇒換算￥416,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

当調査レポートでは、核医学の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、核医学の世界市場規模及び予測、用途別分析、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・核医学の世界市場：市場規模及び予測
・核医学の世界市場：製品別分析
・核医学の世界市場：需要先別分析
・核医学の世界市場：用途別分析
・核医学の世界市場：地域別分析
・核医学の世界市場：アジア市場規模
・核医学の世界市場：アメリカ市場規模
・核医学の世界市場：ヨーロッパ市場規模
・核医学の世界市場：成長要因
・核医学の世界市場：課題
・市場動向
・競争状況
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Nuclear Medicine
Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations that can be detected using a scanner or a detector.
Technavio’s analysts forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2016-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.
The market is divided into the following segments based on geography:
• Americas
• EMEA
• APAC

Technavio’s report, Global Nuclear Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Cardinal Health
• Digirad
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare

[Other prominent vendors]
• ABT Molecular Imaging
• Advanced Accelerator Applications
• AGFA Healthcare
• Algeta
• Astellas Pharma
• Bayer
• Bracco Imaging
• Brain Biosciences
• Capintec
• CMR Naviscan
• Cubresa
• Eczacibasi-Monrol Nuclear Products
• FUJIFILM Holdings
• IBA Molecular Imaging
• ISOLOGIC Innovative Radiopharmaceuticals
• Jubilant DraxImage
• Mallinckrodt
• Mediso Medical Imaging System
• Mirada Medical
• Navidea Biopharmaceuticals
• Nordion
• Piramal Imaging
• Positron Pharmaceutical Company
• RadioMedix
• SHINE Medical Technologies
• Sophie Biosciences
• Toshiba Medical Systems
• Triad Isotopes
• Voxel

[Market driver]
• Growing demand for radiopharmaceuticals
• For a full, detailed list, view our report

[Market challenge]
• High cost of nuclear medicine and time constraints owing to its short half-life
• For a full, detailed list, view our report

[Market trend]
• Partnerships for development of nuclear medicine
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Global nuclear medicine equipment market
• Global SPECT market
• Global PET market
• Global radiopharmaceuticals market

PART 07: Market segmentation by application
• Oncology
• Cardiology
• Neurology

PART 08: Market segmentation by end-user
• Diagnostic centers
• Hospitals
• Research centers

PART 09: Geographical segmentation
• Global nuclear medicine market in Americas
• Reimbursement of radiopharmaceuticals in US
• Global nuclear medicine market in EMEA
• Global nuclear medicine market in APAC

PART 10: Market drivers
• High demand for SPECT and PET imaging
• Rising incidence of cancer and CVDs
• Growing demand for radiopharmaceuticals

PART 11: Impact of drivers

PART 12: Market challenges
• High cost of nuclear medicine and time constraints owing to its short half-life
• Shortage of nuclear medicine
• Regulatory hurdles

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Partnerships for development of nuclear medicine
• Production based on cyclotron
• Growing funding for R&D

PART 15: Vendor landscape
• Competitive scenario

PART 16: Key vendors
• Cardinal Health
• Digirad
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Radioisotopes used in medical imaging
Exhibit 03: Global nuclear medicine market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global nuclear medicine market segmentation by product
Exhibit 06: Global nuclear medicine market segmentation by product 2015
Exhibit 07: Global nuclear medicine market segmentation by product 2020
Exhibit 08: Global nuclear medicine equipment market 2015-2020 ($ billions)
Exhibit 09: Global SPECT market 2015-2020 ($ billions)
Exhibit 10: Global PET market 2015-2020 ($ millions)
Exhibit 11: Global radiopharmaceuticals market 2015-2020 ($ billions)
Exhibit 12: Global nuclear medicine market segmentation by application 2015
Exhibit 13: Global nuclear medicine market segmentation by end-user 2015
Exhibit 14: Global nuclear medicine market segmentation by geography 2015
Exhibit 15: Global nuclear medicine market segmentation by geography 2020
Exhibit 16: Global nuclear medicine market segmentation by geography 2015-2020
Exhibit 17: Global nuclear medicine market segmentation by geography 2015-2020 ($ billions)
Exhibit 18: Conditions diagnosed using nuclear medicine (in the US)
Exhibit 19: Nuclear medicine market in Americas 2015-2020 ($ billions)
Exhibit 20: Components for Medicare reimbursement
Exhibit 21: Difference in Medicare based on hospital facility and physician’s offices
Exhibit 22: Reimbursement provided by Medicare for various nuclear medicines 2015
Exhibit 23: Nuclear medicine market in EMEA 2015-2020 ($ billions)
Exhibit 24: Nuclear medicine market in APAC 2015-2020 ($ millions)
Exhibit 25: Impact of drivers
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Cardinal Health: Product portfolio
Exhibit 28: Cardinal Health: Key takeaways
Exhibit 29: Digirad: Business segmentation by revenue 2015
Exhibit 30: Digirad: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 31: Digirad: Key takeaways
Exhibit 32: GE Healthcare: Product portfolio
Exhibit 33: GE Healthcare: Key takeaways
Exhibit 34: Lantheus Medical Imaging: Product portfolio
Exhibit 35: Regulatory product approvals
Exhibit 36: Lantheus Medical Imaging: Product segmentation by revenue 2015
Exhibit 37: Lantheus Medical Imaging: Product segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 38: Lantheus Medical Imaging: Key takeaways
Exhibit 39: Philips Healthcare: Product portfolio
Exhibit 40: Philips Healthcare: Key takeaways
Exhibit 41: Other prominent vendors



【掲載企業】

Cardinal Health, Digirad, GE Healthcare, Lantheus Medical Imaging, Philips Healthcare, ABT Molecular Imaging, Advanced Accelerator Applications, AGFA Healthcare, Algeta, Astellas Pharma, Bayer, Bracco Imaging, Brain Biosciences, Capintec, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular Imaging, ISOLOGIC Innovative Radiopharmaceuticals, Jubilant DraxImage, Mallinckrodt, Mediso Medical Imaging System, Mirada Medical, Navidea Biopharmaceuticals, Nordion, Piramal Imaging, Positron Pharmaceutical Company, RadioMedix, SHINE Medical Technologies, Sophie Biosciences, Toshiba Medical Systems, Triad Isotopes, Voxel.

【資料のキーワード】

核医学装置、SPECT、PET、放射性医薬品、医療

【調査方法】

一次資料による調査（業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など）及び二次資料による調査（Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど）

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。
[核医学の世界市場：核医学装置、SPECT、PET、放射性医薬品]についてメールでお問い合わせはこちら

※関連データはありません。


◆H&Iグローバルリサーチ株式会社のお客様（例）◆